Moreno Jiménez, María José (Date of defense: 2014-06-10)
Diffuse large B-cell lymphoma (DLBCL) is a clinically and genetically heterogeneous disease, accounting for 30% of all non-Hodgkin lymphoma cases. Although the addition of rituximab to standard treatment ...